查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1702018

單株抗體市場報告（按生產方法、來源、適應症、最終用途和地區）2025 年至 2033 年

Monoclonal Antibodies Market Report by Production Method, Source, Indication, End Use, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

2024年全球單株抗體市場規模達2,358億美元。展望未來， IMARC Group預計到2033年市場規模將達到4,107億美元，2025-2033年期間的成長率（CAGR）為6.04%。癌症、自體免疫疾病和傳染病等慢性疾病的盛行率不斷上升、雙特異性抗體和抗體-藥物偶聯物 (ADC) 等創新、老年人口的增加以及腫瘤學和免疫療法的擴展正在推動市場成長。

單株抗體 (mAb) 是實驗室產生的蛋白質，用作替代抗體，可增強、改變、恢復和模仿免疫系統對有害細胞的攻擊。它們用於檢測和瞄準癌細胞，並透過增強免疫系統來摧毀它們。它們也用於阻斷癌細胞與促進細胞生長的蛋白質之間的連接。此外，它們還能阻止蛋白質的形成，使免疫系統細胞能夠有效地對抗癌細胞。此外，單株抗體可將放射治療直接輸送至癌細胞，並最大限度地減少輻射對健康細胞的影響

單株抗體市場趨勢：

目前，癌症、心臟病、中風、糖尿病和關節炎等慢性病的盛行率不斷上升是推動市場發展的關鍵因素之一。除此之外，領先的製造商正在大力投資研發 (R&D) 活動，以推出增強型 mAb 藥物來治療神經退化性疾病，如阿茲海默症、亨廷頓氏症、帕金森氏症和路易氏體疾病。他們也專注於各種行銷策略來擴大客戶群，這有助於市場的成長。此外，用於治療各種抗原（如癌細胞、免疫抑制和免疫調節分子）的人源化 mAb 的需求不斷增加，為行業投資者提供了豐厚的成長機會。除此之外，全球對用於治療癌症的具有成本效益的生物相似藥 mAb 的需求也在增加。這一趨勢與蓬勃發展的醫療保健產業一起推動著市場的成長。此外，下一代定序等各種基因平台的技術進步正在帶來積極的市場前景。此外，全球先進基因工程技術在 mAb 生產中的應用正在增加。再加上大眾對 mAb 療法益處的認知不斷提高，推動了市場的成長。

本報告回答的關鍵問題

  • 2024 年全球單株抗體市場規模？ 2025-2033年全球單株抗體市場的預期成長率是多少？
  • 推動全球單株抗體市場發展的關鍵因素有哪些？
  • COVID-19 對全球單株抗體市場有何影響？
  • 根據生產方法，全球單株抗體市場如何分佈？
  • 根據來源，全球單株抗體市場的分佈如何？
  • 根據適應症，全球單株抗體市場如何分佈？
  • 根據最終用途，全球單株抗體市場如何分佈？
  • 全球單株抗體市場的主要區域有哪些？
  • 全球單株抗體市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球單株抗體市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依生產方式

  • 體內
  • 體外

第7章：市場區隔：依來源

  • 鼠類
  • 嵌合
  • 人性化
  • 人類

第8章：市場區隔：依指標

  • 癌症
  • 自體免疫疾病
  • 發炎性疾病
  • 傳染病
  • 其他

第 9 章：市場區隔：最終用途別

  • 醫院
  • 研究機構
  • 其他

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AbbVie Inc.
    • Amgen Inc.
    • Biogen Inc.
    • F. Hoffmann-La Roche AG
    • GSK plc
    • Johnson & Johnson
    • Merck KGaA
    • Novartis AG
    • Novo Nordisk A/S
    • Pfizer Inc.
    • Sanofi SA
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A6278

The global monoclonal antibodies market size reached USD 235.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 410.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.04% during 2025-2033. The rising prevalence of chronic disorders such as cancer, autoimmune disorders, and infectious diseases, innovations like bispecific antibodies and antibody-drug conjugates (ADCs), increasing geriatric population, and the expansion in oncology and immunotherapy are propelling the market growth.

Monoclonal antibodies (mAbs) are laboratory-produced proteins used to serve as substitute antibodies that can enhance, modify, restore, and mimic the attack of the immune system on unwanted cells. They are utilized for detecting and targeting cancer cells for destruction by enhancing the immune system. They are also employed to block the connection between a cancer cell and proteins that promote cell growth. In addition, they prevent the formation of proteins for enabling immune system cells to work efficiently against cancer cells. Besides this, mAbs transport the radiation treatment directly to cancer cells and minimize the effect of radiation on healthy cells

Monoclonal Antibodies Market Trends:

At present, the growing prevalence of chronic diseases, such as cancer, heart disease, stroke, diabetes, and arthritis, represents one of the key factors driving the market. Besides this, leading manufacturers are extensively investing in research and development (R&D) activities to introduce enhanced mAb drugs for treating neurodegenerative diseases, such as Alzheimer's, Huntington's, Parkinson's, and Lewy body diseases. They are also focusing on various marketing strategies to expand their customer base, which is contributing to the growth of the market. In addition, the increasing demand for humanized mAbs to treat various antigens, such as cancer cells, immunosuppression, and immunomodulatory molecules, are offering lucrative growth opportunities to industry investors. Apart from this, there is a rise in the demand for cost-efficient biosimilar mAbs to treat cancer across the globe. This, along with the burgeoning healthcare industry, is propelling the growth of the market. Moreover, technological advancements in various genetic platforms, such as next-generation sequencing, is offering a positive market outlook. Additionally, there is an increase in the employment of advanced genetic engineering technology in mAbs production around the world. This, coupled with the rising awareness among the masses about the benefits of mAb therapy, is bolstering the market growth.

Key Market Segmentation:

Breakup by Production Method:

  • In Vivo
  • In Vitro

Breakup by Source:

  • Murine
  • Chimeric
  • Humanized
  • Human

Breakup by Indication:

  • Cancer
  • Autoimmune Diseases
  • Inflammatory Diseases
  • Infectious Diseases
  • Others

Breakup by End Use:

  • Hospitals
  • Research Institutes
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., Biogen Inc., F. Hoffmann-La Roche AG, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global monoclonal antibodies market in 2024?
  • 2.What is the expected growth rate of the global monoclonal antibodies market during 2025-2033?
  • 3.What are the key factors driving the global monoclonal antibodies market?
  • 4.What has been the impact of COVID-19 on the global monoclonal antibodies market?
  • 5.What is the breakup of the global monoclonal antibodies market based on the production method?
  • 6.What is the breakup of the global monoclonal antibodies market based on the source?
  • 7.What is the breakup of the global monoclonal antibodies market based on the indication?
  • 8.What is the breakup of the global monoclonal antibodies market based on the end use?
  • 9.What are the key regions in the global monoclonal antibodies market?
  • 10.Who are the key players/companies in the global monoclonal antibodies market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Monoclonal Antibodies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Production Method

  • 6.1 In Vivo
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 In Vitro
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Source

  • 7.1 Murine
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chimeric
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Humanized
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Human
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Indication

  • 8.1 Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Autoimmune Diseases
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Inflammatory Diseases
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Infectious Diseases
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End Use

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AbbVie Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Amgen Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Biogen Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 F. Hoffmann-La Roche AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 GSK plc
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Merck KGaA
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Novartis AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Novo Nordisk A/S
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Sanofi S.A.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Monoclonal Antibodies Market: Major Drivers and Challenges
  • Figure 2: Global: Monoclonal Antibodies Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Monoclonal Antibodies Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Monoclonal Antibodies Market: Breakup by Production Method (in %), 2024
  • Figure 5: Global: Monoclonal Antibodies Market: Breakup by Source (in %), 2024
  • Figure 6: Global: Monoclonal Antibodies Market: Breakup by Indication (in %), 2024
  • Figure 7: Global: Monoclonal Antibodies Market: Breakup by End Use (in %), 2024
  • Figure 8: Global: Monoclonal Antibodies Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Monoclonal Antibodies (In Vivo) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Monoclonal Antibodies (In Vivo) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Monoclonal Antibodies (In Vitro) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Monoclonal Antibodies (In Vitro) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Monoclonal Antibodies (Murine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Monoclonal Antibodies (Murine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Monoclonal Antibodies (Chimeric) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Monoclonal Antibodies (Chimeric) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Monoclonal Antibodies (Humanized) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Monoclonal Antibodies (Humanized) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Monoclonal Antibodies (Human) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Monoclonal Antibodies (Human) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Monoclonal Antibodies (Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Monoclonal Antibodies (Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Monoclonal Antibodies (Autoimmune Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Monoclonal Antibodies (Autoimmune Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Monoclonal Antibodies (Inflammatory Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Monoclonal Antibodies (Inflammatory Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Monoclonal Antibodies (Infectious Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Monoclonal Antibodies (Infectious Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Monoclonal Antibodies (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Monoclonal Antibodies (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Monoclonal Antibodies (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Monoclonal Antibodies (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Monoclonal Antibodies (Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Monoclonal Antibodies (Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Monoclonal Antibodies (Other End Uses) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Monoclonal Antibodies (Other End Uses) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: North America: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: North America: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: United States: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: United States: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Canada: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Canada: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Asia-Pacific: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Asia-Pacific: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: China: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: China: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Japan: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Japan: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: India: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: India: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: South Korea: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: South Korea: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Australia: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Australia: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Indonesia: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Indonesia: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Europe: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Europe: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Germany: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Germany: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: France: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: France: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: United Kingdom: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: United Kingdom: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Italy: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Italy: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Spain: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Spain: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Russia: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Russia: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Latin America: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Latin America: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Brazil: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Brazil: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Mexico: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Mexico: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Others: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Middle East and Africa: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Middle East and Africa: Monoclonal Antibodies Market: Breakup by Country (in %), 2024
  • Figure 85: Middle East and Africa: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Global: Monoclonal Antibodies Industry: SWOT Analysis
  • Figure 87: Global: Monoclonal Antibodies Industry: Value Chain Analysis
  • Figure 88: Global: Monoclonal Antibodies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Monoclonal Antibodies Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Monoclonal Antibodies Market Forecast: Breakup by Production Method (in Million USD), 2025-2033
  • Table 3: Global: Monoclonal Antibodies Market Forecast: Breakup by Source (in Million USD), 2025-2033
  • Table 4: Global: Monoclonal Antibodies Market Forecast: Breakup by Indication (in Million USD), 2025-2033
  • Table 5: Global: Monoclonal Antibodies Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 6: Global: Monoclonal Antibodies Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Monoclonal Antibodies Market: Competitive Structure
  • Table 8: Global: Monoclonal Antibodies Market: Key Players